相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
Robert A. Hauser et al.
LANCET NEUROLOGY (2011)
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Medical Treatment of Parkinson Disease
Mark Stacy
NEUROLOGIC CLINICS (2009)
Adenosine, adenosine A2A antagonists, and Parkinson's disease
P. Jenner et al.
PARKINSONISM & RELATED DISORDERS (2009)
Epidemiology of Parkinson's disease
Guido Alves et al.
JOURNAL OF NEUROLOGY (2008)
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Jose A. Obeso et al.
MOVEMENT DISORDERS (2008)
Adenosine A2A receptors and basal ganglia physiology
S. N. Schiffmann et al.
PROGRESS IN NEUROBIOLOGY (2007)
Potent, selective, and orally active adenosine A2A receptor antagonists:: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
Bernard R. Neustadt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of L-DOPA-induced dyskinesia
M Lundblad et al.
JOURNAL OF NEUROCHEMISTRY (2003)
A(2A) adenosine receptors in human peripheral blood cells
S Gessi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
